HS-10390
- Generic Name
- HS-10390
A Study of the Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy
Phase 2
Not yet recruiting
- Conditions
- Immunoglobulin a Nephropathy
- Interventions
- First Posted Date
- 2024-10-10
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- Hansoh BioMedical R&D Company
- Target Recruit Count
- 90
- Registration Number
- NCT06635772
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath